Free Trial

Calumet (NASDAQ:CLMT) Stock Price Down 2.7% on Insider Selling

Calumet logo with Oils/Energy background

Calumet, Inc. (NASDAQ:CLMT - Get Free Report) was down 2.7% on Wednesday after an insider sold shares in the company. The company traded as low as $16.27 and last traded at $16.43. Approximately 209,452 shares traded hands during mid-day trading, a decline of 78% from the average daily volume of 958,886 shares. The stock had previously closed at $16.88.

Specifically, Director Jennifer Straumins sold 100,000 shares of Calumet stock in a transaction on Monday, June 16th. The stock was sold at an average price of $16.23, for a total transaction of $1,623,000.00. Following the transaction, the director now directly owns 934,589 shares in the company, valued at approximately $15,168,379.47. The trade was a 9.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jennifer Straumins sold 50,000 shares of Calumet stock in a transaction on Friday, June 13th. The shares were sold at an average price of $15.08, for a total transaction of $754,000.00. Following the transaction, the director now owns 1,034,589 shares in the company, valued at approximately $15,601,602.12. This trade represents a 4.61% decrease in their position. The disclosure for this sale can be found here. In other Calumet news, SVP Gregory J. Morical sold 25,123 shares of the stock in a transaction on Monday, June 16th. The stock was sold at an average price of $16.69, for a total value of $419,302.87. Following the completion of the sale, the senior vice president now owns 39,415 shares in the company, valued at approximately $657,836.35. This represents a 38.93% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Wall Street Analyst Weigh In

Several research firms have weighed in on CLMT. Wells Fargo & Company dropped their price target on Calumet from $23.00 to $21.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. HC Wainwright restated a "buy" rating and set a $33.00 target price on shares of Calumet in a research report on Monday, March 3rd. TD Cowen downgraded shares of Calumet from a "buy" rating to a "hold" rating and reduced their price target for the company from $26.00 to $16.00 in a report on Tuesday, March 4th. Bank of America initiated coverage on shares of Calumet in a research note on Tuesday, May 13th. They issued a "buy" rating and a $15.00 price target on the stock. Finally, UBS Group upgraded Calumet from a "sell" rating to a "neutral" rating and cut their price objective for the company from $15.00 to $12.00 in a research report on Monday, March 17th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $18.50.

Check Out Our Latest Analysis on Calumet

Calumet Stock Performance

The stock has a fifty day moving average of $12.78 and a 200-day moving average of $15.17. The company has a market cap of $1.41 billion, a PE ratio of -4.09 and a beta of 0.91.

Calumet (NASDAQ:CLMT - Get Free Report) last issued its earnings results on Friday, May 9th. The oil and gas company reported ($1.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.62). The firm had revenue of $993.90 million for the quarter, compared to analysts' expectations of $899.62 million. The company's revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the prior year, the company earned ($0.51) earnings per share. As a group, equities analysts anticipate that Calumet, Inc. will post -3.02 EPS for the current fiscal year.

Calumet Company Profile

(Get Free Report)

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Further Reading

Should You Invest $1,000 in Calumet Right Now?

Before you consider Calumet, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet wasn't on the list.

While Calumet currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines